The Journal of allergy and clinical immunology
-
J. Allergy Clin. Immunol. · Jul 2017
Randomized Controlled Trial Multicenter StudyA randomized multicenter study evaluating Xolair persistence of response after long-term therapy.
Few data are available to assist clinicians with decisions regarding long-term use of asthma therapies, including omalizumab. ⋯ Continuation of omalizumab after long-term treatment results in continued benefit, as evidenced by improved symptom control and reduced exacerbation risk.